Odonate Therapeutics, Inc. Retained Earnings
Odonate Therapeutics, Inc. had Retained Earnings of -$436.21 million as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2021-11-10
- 2021-09-30: Retained Earnings (Accumulated Deficit) -$436.21M.
- 2021-06-30: Retained Earnings (Accumulated Deficit) -$422.21M.
- 2021-03-31: Retained Earnings (Accumulated Deficit) -$400.19M.
- 2020-12-31: Retained Earnings (Accumulated Deficit) -$366.43M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2021-09-30 | -$436.21M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$422.21M 10-Q · filed 2021-07-27 |
| 2021-03-31 | -$400.19M 10-Q · filed 2021-05-14 |
| 2020-12-31 | -$366.43M 10-Q · filed 2021-11-10 |
| 2020-09-30 | -$334.14M 10-Q · filed 2020-10-28 |
| 2020-06-30 | -$303.66M 10-Q · filed 2020-07-30 |
| 2020-03-31 | -$270.24M 10-Q · filed 2020-04-28 |
| 2019-12-31 | -$240.08M 10-K · filed 2021-02-23 |
| 2019-09-30 | -$212.23M 10-Q · filed 2019-11-06 |
| 2019-06-30 | -$185.60M 10-Q · filed 2019-07-24 |
| 2019-03-31 | -$156.90M 10-Q · filed 2019-04-25 |
| 2018-12-31 | -$128.25M 10-K · filed 2020-02-20 |
| 2018-09-30 | -$99.49M 10-Q · filed 2018-10-23 |
| 2018-06-30 | -$75.56M 10-Q · filed 2018-07-30 |
| 2018-03-31 | -$56.17M 10-Q · filed 2018-05-03 |
| 2017-12-31 | -$39.29M 10-K · filed 2019-02-22 |